CytoSorbents
Data Breaches, Cyber Attacks and Security Report

https://cytosorbents.com  ᛫  Manufacturing
Last updated September 21, 2019

About CytoSorbents

Company Overview

Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.CytoSorb, the company's first product to market, received its CE mark approval in 2011.CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins.

Valuation

Employees

CEO

Phillip Chan

Location

Data Breaches and Security News

CytoSorbents Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CytoSorbents is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for CytoSorbents

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare CytoSorbents's security performance with other companies